It is important for pediatricians to understand how TFTs are affected by obesity, when to order thyroid function tests, and when to refer.
Thyroid hormone replacement is a critical element in the overall management of patients with thyroid cancer.
Familial non-medullary thyroid cancer (FNMTC) constitutes 3–9% of all thyroid cancer cases and is divided into syndromic and non-syndromic FNMTC.
After receiving a diagnosis of papillary thyroid cancer, intuitively, the thought has been that surgery is the next step. While this was the standard in the past, we now know that in specific situations immediate surgery may not be necessary.